Elevated levels of plasma free fatty acids (FFA), which are commonly found in 43 obesity, induce insulin resistance. FFA activate protein kinases including the 44 proinflammatory IκBα kinase β (IKKβ), leading to serine phosphorylation of insulin 45 receptor substrate 1 (IRS-1) and impaired insulin signaling. In order to test whether 46 resveratrol, a polyphenol found in red wine, prevents FFA-induced insulin resistance, we 47 used a hyperinsulinemic-euglycemic clamp with tracer to assess hepatic and peripheral 48 insulin sensitivity in overnight-fasted Wistar rats infused for 7 hours with either saline, 49
MATERIALS AND METHODS 113

Animal care and surgery 114
For all experiments female Wistar rats (Charles River, Quebec, Canada) weighing 115 250-300g were used. The rats were exposed to a 12h light-dark cycle and were fed rat Rats were allowed 3-5 days to adapt to the facility. Thereafter, they underwent 122 vessel cannulation under isofluorane anesthesia as previously described (Park et al. 123 2007b) . Polyethylene catheters (PE-50; Cay Adams, Boston, MA), each extended with a 124 segment of silastic tubing (internal diameter of 0.58 mm, length of 3 cm; Dow Corning, 125
Midland, MI), were inserted into the right atrium via the jugular vein for infusion and 126 into the aortic arch via the carotid artery for blood sampling. Both catheters were 127 tunneled subcutaneously, exteriorized, filled with heparin (1,000 U/ml) in 60% 128 polyvinylpyrrolidone to maintain patency and finally closed with a metal pin. The rats 129
were allowed a minimum of 3 day recovery from surgery before experiments were 130 carried out. 3 H] glucose to maintain plasma glucose specific activity constant. Total 148 blood withdrawal was ~3.8 ml. After plasma separation, the red blood cells were diluted 149 1:1 in heparinized saline (4 U/ml) and re-infused into the rats. Upon completion of the 150 experiments, the rats were anesthetized with i.v. administration of an anesthetic cocktail 151 (ketamine: xylazine: acepromazine (87: 1.7: 0.4 mg/ml) and soleus skeletal muscle was 152
collected. 153
Plasma Assays 154 D r a f t Plasma insulin levels were determined by radioimmunoassays (RIAs) using kits 155 specific for rodent insulin (but with 100% cross reactivity with porcine insulin used for 156 infusion) as previously described (Park et al. 2007b and of the radiolabeled glucose infusate were assayed together with the plasma samples 161 (Lam et al. 2002) . Plasma FFA levels were assayed using a colorimetric kit from Wako 162 Industrials (Osaka, Japan) as previously described (Park et al. 2007b; Lam et al. 2002) . 163
Immunoblot Analysis 164
Soleus muscle samples (40 mg) were ground in a glass-on-glass tissue grinder 165 containing ice-cold lysis buffer (50 mM Tris pH 7.5, 1% Nonidet P-40, 150 mM NaCl, 166 1 mM MgCl 2 , 1 mM CaCl 2 , 2 mM EGTA, 1 mM Na 3 VO 4 , 100 mM NaF, 10 mM 167 Na 4 P 2 O 4 , 1 µM okadaic acid, 1 mM PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin). 168 MDA assay: The MDA assay was carried out as previously described (Pereira et al. 191 
2015) 192
Plasma resveratrol measurements 193
Resveratrol was extracted from rat plasma samples using ethyl acetate and 194 centrifuging at 8000 rpm for 1 minute at 4ºC. Supernatant was collected and dried using a 195 
Statistical analysis 218
One-way analysis of variance (ANOVA) followed by Tukey's t test was used to 219 compare differences between treatments groups. Significance was accepted at P<0.05. 220
Statistical calculations were performed using the statistical program SPSS (IBM 221
Corporation, Armonk, NY, USA). 222 223 D r a f t RESULTS 
224
Plasma insulin levels, as expected, were markedly elevated from basal during the 225 clamp due to infusion of exogenous insulin (Table 1) . There was no difference in plasma 226 insulin levels between groups during the basal period or during the clamp. Plasma 227 glucose levels were not different between groups during the basal period and during the 228 clamp (Table 1) . Plasma FFA levels during the basal period were ~ 2-fold higher in the 229 IH and IH plus RSV groups compared to the SAL group. As expected, plasma FFA 230 levels were lower during the hyperinsulinemic clamp than during the basal period in all 231 groups due to plasma FFA-lowering effect of insulin, but remained higher in the IH and 232
IH+RSV groups compared to controls. resveratrol infusion alone (162+8 µmol kg -1 min -1 ) had no effect. 239
During the basal period, no differences in endogenous glucose production (EGP) 240 (Figure 2A ) between treatment groups were observed. Hepatic insulin sensitivity is 241 measured as the ability of insulin to suppress EGP from basal. In the SAL group, EGP 242 was suppressed by 40% during the last 30 min of hyperinsulinemic clamp (Figure 2A and 243 2B). In contrast, in the IH group, the suppression of EGP during the clamp was only 2%, 244
i.e. significantly less than the EGP suppression in the SAL group (P<0.05; Figure 2B ). Resveratrol infusion alone had no effect. 257
In an attempt to understand the mechanism of resveratrol action to prevent the IH-258 induced peripheral insulin resistance we examined total and ser 307 phosphorylation 259 levels of IRS-1 in soleus skeletal muscle. To investigate whether IH and resveratrol had an effect on oxidative stress, we 280 measured MDA levels in skeletal muscle and found that IH did not affect MDA levels in 281 muscle compared to SAL and that MDA levels were higher in the IH+RSV group 282 compared to the IH group (Figure 7) . 283
Using UPLC we measured resveratrol levels in rat plasma samples. The average 284 resveratrol level in the plasma of 3-rats infused with resveratrol for 7h at the dose of the 285 present study was 1.064 µM while no resveratrol was detected before resveratrol infusion. 1992). Therefore, we chose to study soleus muscle to maximize the probability of finding 348 differences in insulin sensitivity. 349
In the present study, we show that IH infusion causes a marked increase in serine However, we found that IH infusion did not increase levels of MDA, a marker of 390 oxidative stress, in skeletal muscle and that MDA levels were higher in the IH+RSV 391 group compared to the IH group. Based on this marker of oxidative stress, we suggest 392 that oxidative stress is not a key mediator of IH-induced insulin resistance in skeletal 393 muscle and the ability of resveratrol to act as an antioxidant does not play a protective 394 role in our study. We cannot exclude the possibility that the mechanisms through which 395 resveratrol improves insulin sensitivity differ depending on the duration of resveratrol 396 administration. For example, it has been reported that the ability of resveratrol to elevate 397 antioxidant enzyme activity occurs after prolonged exposure (Martins et al. 2014) , and 398 therefore, resveratrol's antioxidant properties may not explain how it improves insulin 399 sensitivity in our acute model. Liver tissue was not collected in the present study and 400 therefore whether resveratrol has similar effects on liver IRS and IκBα remains to be 401 Furthermore, in AMPK deficient mice fat-induced insulin resistance was not prevented 412 by resveratrol (Um et al. 2010) . High-fat diet used in these studies is typically 413 associated with chronically elevated plasma FFA. We found no changes in total and 414 phosphorylated AMPK levels, indicating that AMPK is not activated by resveratrol in our 415
short-term lipid infusion insulin resistance model. 416
In conclusion, the present study demonstrates that resveratrol prevents hepatic and 417 
